Vaishali Sanchorawala, MD

Articles by Vaishali Sanchorawala, MD

Experts on RCC

First-Line Therapy in Advanced Clear Cell RCC: Novel Doublet Regimens

ByThomas Powles, MD,Rana R. McKay, MD,Vaishali Sanchorawala, MD,Eric Jonasch, MD,Benjamin Maughan, MD

October 20th 2022

An expert panel reviews novel first-line doublet therapies being studied in patients with advanced clear cell renal cell carcinoma.

Vaishali Sanchorawala, MD, of Boston Medical Center

Dr. Sanchorawala on the Impact of Depth of Renal and Cardiac Response on Survival in AL Amyloidosis

ByVaishali Sanchorawala, MD

September 10th 2021

Vaishali Sanchorawala, MD, discusses the impact of renal and cardiac response on survival in patients with light chain amyloidosis.

Latest Updated Articles

Trending on OncLive

FDA Approves Zanidatamab-Based Regimens for First-Line HER2+ Locally Advanced or Metastatic Gastric Cancer

FDA Grants Fast Track Designation to Pan-RAS Molecular Glue ERAS-0015 for Metastatic Pancreatic Adenocarcinoma

FDA Grants Priority Review to Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer

MOMENTUM Trial Aims to Add Further Evidence for Cemsidomide in R/R Myeloma

Amivantamab Monotherapy Yields Durable Responses in Pretreated R/M HNSCC